POEMS syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| POEMS syndrome | |
|---|---|
| File:Plasma cells.jpg | |
| Synonyms | Crow–Fukase syndrome, Takatsuki disease |
| Pronounce | |
| Specialty | Hematology, Neurology |
| Symptoms | Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes |
| Complications | N/A |
| Onset | Middle age |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, associated with monoclonal plasma cell disorder |
| Risks | |
| Diagnosis | Clinical evaluation, blood tests, imaging studies, biopsy |
| Differential diagnosis | Multiple myeloma, Chronic inflammatory demyelinating polyneuropathy, Amyloidosis |
| Prevention | N/A |
| Treatment | Radiation therapy, Chemotherapy, Corticosteroids, Stem cell transplantation |
| Medication | N/A |
| Prognosis | Variable, depends on response to treatment |
| Frequency | Rare |
| Deaths | N/A |
POEMS syndrome is a rare paraneoplastic syndrome that is associated with an underlying plasma cell disorder. The acronym "POEMS" stands for the five main features of the syndrome: Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal plasma cell disorder, and Skin changes.
Clinical Features[edit]
Polyneuropathy[edit]
Polyneuropathy in POEMS syndrome is typically a symmetric, demyelinating neuropathy that affects both sensory and motor nerves. Patients often present with weakness, numbness, and tingling in the extremities.
Organomegaly[edit]
Organomegaly refers to the abnormal enlargement of organs. In POEMS syndrome, this often includes hepatomegaly (enlarged liver), splenomegaly (enlarged spleen), and lymphadenopathy (enlarged lymph nodes).
Endocrinopathy[edit]
Endocrinopathy in POEMS syndrome can involve multiple endocrine glands. Common manifestations include hypogonadism, hypothyroidism, and diabetes mellitus.
Monoclonal Plasma Cell Disorder[edit]
The presence of a monoclonal plasma cell disorder is a hallmark of POEMS syndrome. This is often detected as a monoclonal protein in the blood or urine, and may be associated with osteosclerotic myeloma.
Skin Changes[edit]
Skin changes in POEMS syndrome can include hyperpigmentation, hemangiomas, and hypertrichosis. These changes are often noticeable and can be a key diagnostic feature.
Pathophysiology[edit]
The exact pathophysiology of POEMS syndrome is not fully understood, but it is believed to be related to the overproduction of cytokines by the abnormal plasma cells. Vascular endothelial growth factor (VEGF) is one cytokine that is often elevated in patients with POEMS syndrome and may play a role in the disease manifestations.
Diagnosis[edit]
The diagnosis of POEMS syndrome is based on the presence of the major criteria (polyneuropathy and monoclonal plasma cell disorder) along with at least one of the minor criteria (organomegaly, endocrinopathy, skin changes, etc.). Additional tests may include electromyography (EMG), nerve conduction studies, and bone marrow biopsy.
Treatment[edit]
Treatment of POEMS syndrome often involves addressing the underlying plasma cell disorder. This can include therapies such as radiation therapy, chemotherapy, and autologous stem cell transplantation. Supportive care for symptoms such as neuropathy and endocrinopathy is also important.
Prognosis[edit]
The prognosis for patients with POEMS syndrome varies depending on the severity of the disease and the response to treatment. Early diagnosis and treatment can improve outcomes.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian